Envista Holdings

Valuation Analysis

About the Company

Envista Holdings en bref

Envista Holdings (NVST) is currently trading at 23,68 € with a market capitalization of 3,9 Md €. The trailing P/E ratio stands at 66.61x, with a forward P/E of 17.38x. The 52-week range spans from 16,27 € to 26,37 €; the current price is 10.2% below the yearly high. Year-over-year revenue growth stands at +14.4%. The net profit margin stands at 2.41%.

💰 Dividende

Envista Holdings currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

14 analystes évaluent Envista Holdings (NVST) au consensus : Acheter. L'objectif de cours moyen est de 25,52 €, soit un potentiel de +7.76% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 18,21 € à 30,35 €.

Envista Holdings : la thèse d'investissement en détail

Envista Holdings (NVST) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 14.4% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 130% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

Le scénario baissier

With a net margin of just 2.41%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

À surveiller

• The forward P/E of 17.38x is meaningfully below the trailing 66.61x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (6.45%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Envista Holdings?

Compare top-rated brokers — low fees, trusted providers, fully regulated.